文献速递骨肌儿科影像介入CTUS

儿童医院青少年及成人患者肌肉骨骼疼痛检查中诊断性影像引导注射的临床影响:初步结果

Clinical impact of diagnostic image-guided injections for musculoskeletal pain work-up in adolescent and adult patients at a children's hospital: initial results.
PubMed 文献 · Skeletal Radiol · 2024-03-02

回顾性研究纳入2020年8月至2023年3月在儿童医院接受透视或超声引导下诊断性肌肉骨骼注射的109例转诊患者(平均17.6岁),注射罗哌卡因和曲安奈德。89.0%即刻疼痛改善,67.9%在2-3天后改善,净84.4%基于疼痛评分和临床检查显示改善;注射部位疼痛改善者接受手术干预或额外治疗性注射的比例显著高于无改善者(88% vs 35.3%,P<0.0001)。15.6%无疼痛改善者中17.6%最终在注射部位以外发现替代病因并接受手术干预。

要点

  • 诊断性MSK注射后净84.4%转诊显示疼痛改善,有助于增强治疗决策信心。
  • 注射部位疼痛改善者接受手术或额外治疗性注射的比例为88%,无改善者为35.3%(P<0.0001)。
  • 15.6%转诊无疼痛改善,其中17.6%在注射部位以外发现替代病因并接受手术干预。

核心结论

  • 影像引导下MSK注射在肌肉骨骼疾病管理中起重要作用,84.4%转诊症状缓解,增强治疗决策信心;15.6%患者发现替代病因,完全改变管理方案。

研究设计与样本

  • 回顾性研究,纳入2020年8月至2023年3月在儿童医院接受透视或超声引导下诊断性MSK注射的109例转诊患者(平均17.6岁),注射罗哌卡因和曲安奈德,评估对患者管理的影响。

关键影像表现/征象

  • 注射部位最常见为髋部(76.2%),其次为踝部(9.2%)和髂腰肌腱鞘(8.3%)。
  • 疼痛改善即刻发生率为89.0%,2-3天后为67.9%,基于疼痛评分和临床检查的净改善率为84.4%。

诊断标准与关键数值

  • 使用FACES疼痛评分在注射前、注射后即刻及注射后2-3天进行定量评估。
  • 注射部位疼痛改善者接受手术干预或额外治疗性注射的发生率为88%,无改善者为35.3%(P<0.0001)。
  • 无疼痛改善的15.6%(N=17)转诊中,17.6%(n=3)最终在诊断性注射部位以外接受手术干预。

临床应用与阅片要点

  • 诊断性MSK注射后疼痛改善与后续手术或治疗性注射需求增加相关(88% vs 35.3%,P<0.0001)。
  • 注射部位无疼痛改善时需考虑替代病因,本研究中17.6%的无改善者在其他部位发现病因并接受手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the clinical impact of diagnostic musculoskeletal (MSK) injections on treatment decision-making in adolescent and adult patients at a children's hospital.

MATERIALS AND METHODS: Retrospective study in patients who underwent diagnostic MSK injections by fluoroscopy or ultrasound (US) between 8/2020 and 3/2023 at a children's hospital. Patients received ropivacaine and triamcinolone acetonide at pain site, reporting quantitative FACES pain score prior to, immediately following, and 2-3 days following injection. Impact on patient care was subsequently assessed.

RESULTS: A total of 109 diagnostic fluoroscopic or US MSK injection referrals (mean: 17.6 years old) were included, most commonly hip (76.2%), ankle (9.2%), and iliopsoas tendon sheath (8.3%). Pain improvement occurred in 89.0% immediately and 67.9% 2-3 days after MSK injection, with net 84.4% exhibiting improvement based on pain scores and clinical exams. When there was pain improvement at the site of injection, there was a statistically higher incidence of operative intervention or additional therapeutic injections compared with the cohort that did not have symptom improvement (88% versus 35.3%, P < 0.0001). For the 15.6% (N = 17) of referrals that did not have pain improvement, 17.6% (n = 3) ultimately had an operative intervention at a separate site from the diagnostic injection, as an alternative etiology for the pain was found.

CONCLUSION: Image-guided MSK injections play an important role in the management of musculoskeletal disorders. 84.4% of referrals experienced symptom relief, improving confidence for treatment decision-making. Importantly, 15.6% of patients were found to have an alternative etiology for symptoms, altering management altogether.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Tran E, Rosenfeld S, Ngan E, et al. Clinical impact of diagnostic image-guided injections for musculoskeletal pain work-up in adolescent and adult patients at a children's hospital: initial results. Skeletal Radiol. 2024. PMID: 38430274. doi:10.1007/s00256-024-04635-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。